학술논문

FINAL RESULTS OF THE PHASE 3 STUDIES NORTHSTAR-2 AND NORTHSTAR-3 IN PATIENTS WITH TRANSFUSION-DEPENDENT beta-THALASSEMIA (TDT): SUBGROUP ANALYSIS OF ITALIAN PATIENTS TREATED WITH BETIBEGLOGENE AUTOTEMCEL (BETI-CEL), LENTIGLOBIN FOR THALASSEMIA
Document Type
Journal
Source
HAEMATOLOGICA; OCT 2021, 106 10, p32-p32, 1p. Supplement: 3
Subject
Language
English
ISSN
03906078